Impact of preexisting coronary artery and peripheral artery disease on outcomes in diabetic patients after kidney transplant

Author:

Jiwani Sania1ORCID,Chan Wan-Chi1,Majmundar Monil1,Patel Kunal N2,Mehta Harsh1,Sharma Aditya3ORCID,Parmar Gaurav4,Wiley Mark1,Tadros Peter1,Hockstad Eric1,Yarlagadda Sri G5,Gupta Aditi5,Gupta Kamal1ORCID

Affiliation:

1. Department of Cardiovascular Medicine, University of Kansas Medical Center, Kansas City, KS, USA

2. Department of Cardiovascular Medicine, West Virginia University Hospital, Morgantown, WV, USA

3. Division of Cardiovascular Medicine, University of Virginia, Charlottesville, VA, USA

4. Section of Vascular Medicine, Massachusetts General Hospital, Boston, MA, USA

5. Department of Internal Medicine, Division of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, KS, USA

Abstract

Background: Atherosclerotic cardiovascular disease is highly prevalent in patients with end-stage kidney disease (ESKD). Kidney transplant (KT) improves patient survival and cardiovascular outcomes. The impact of preexisting coronary artery disease (CAD) and peripheral artery disease (PAD) on posttransplant outcomes remains unclear. Methods: This is a retrospective study utilizing the United States Renal Data System. Adult diabetic dialysis patients who underwent first KT between 2006 and 2017 were included. The study population was divided into four cohorts based on presence of CAD/PAD: (1) polyvascular disease (CAD + PAD); (2) CAD without PAD; (3) PAD without CAD; (4) no CAD or PAD (reference cohort). The primary outcome was 3-year all-cause mortality. Secondary outcomes were incidence of posttransplant myocardial infarction (MI), cerebrovascular accidents (CVA), and graft failure. Results: The study population included 19,329 patients with 64.4% men, mean age 55.4 years, and median dialysis duration of 2.8 years. Atherosclerotic cardiovascular disease was present in 28% of patients. The median follow up was 3 years. All-cause mortality and incidence of posttransplant MI were higher with CAD and highest in patients with polyvascular disease. The cohort with polyvascular disease had twofold higher all-cause mortality (16.7%, adjusted hazard ratio (aHR) 1.5, p < 0.0001) and a fourfold higher incidence of MI (12.7%, aHR 3.3, p < 0.0001) compared to the reference cohort (8.0% and 3.1%, respectively). There was a higher incidence of posttransplant CVA in the cohort with PAD (3.4%, aHR 1.5, p = 0.01) compared to the reference cohort (2.0%). The cohorts had no difference in graft failure rates. Conclusions: Preexisting CAD and/or PAD result in worse posttransplant survival and cardiovascular outcomes in patients with diabetes mellitus and ESKD without a reduction in graft survival.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. United States Renal Data System. 2022 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, https://adr.usrds.org/2022 (2022, accessed 5 June 2023)

2. Diagnosis and Management of Cardiovascular Disease in Advanced and End‐Stage Renal Disease

3. The prevalence and prognostic implications of polyvascular atherosclerotic disease in patients with chronic kidney disease

4. Peripheral Arterial Disease and Renal Transplantation

5. Acute Coronary Syndromes after Renal Transplantation in Patients with End-Stage Renal Disease Resulting from Diabetes

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3